103 related articles for article (PubMed ID: 15675611)
1. TAK-375 Takeda.
Cajochen C
Curr Opin Investig Drugs; 2005 Jan; 6(1):114-21. PubMed ID: 15675611
[TBL] [Abstract][Full Text] [Related]
2. Ramelteon: TAK 375.
Drugs R D; 2005; 6(3):186-8. PubMed ID: 15869323
[TBL] [Abstract][Full Text] [Related]
3. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
4. [A novel therapeutic drug: ramelteon].
Miyamoto M
Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
Kato K; Hirai K; Nishiyama K; Uchikawa O; Fukatsu K; Ohkawa S; Kawamata Y; Hinuma S; Miyamoto M
Neuropharmacology; 2005 Feb; 48(2):301-10. PubMed ID: 15695169
[TBL] [Abstract][Full Text] [Related]
6. Ramelteon: profile of a new sleep-promoting medication.
Owen RT
Drugs Today (Barc); 2006 Apr; 42(4):255-63. PubMed ID: 16703122
[TBL] [Abstract][Full Text] [Related]
7. Ramelteon (Rozerem) for insomnia.
Med Lett Drugs Ther; 2005 Nov; 47(1221):89-91. PubMed ID: 16267494
[No Abstract] [Full Text] [Related]
8. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
9. Fresh from the pipeline: Ramelteon.
Buysse D; Bate G; Kirkpatrick P
Nat Rev Drug Discov; 2005 Nov; 4(11):881-2. PubMed ID: 16299918
[No Abstract] [Full Text] [Related]
10. Efficacy and clinical safety of ramelteon: an evidence-based review.
Sateia MJ; Kirby-Long P; Taylor JL
Sleep Med Rev; 2008 Aug; 12(4):319-32. PubMed ID: 18603221
[TBL] [Abstract][Full Text] [Related]
11. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.
Roth T; Stubbs C; Walsh JK
Sleep; 2005 Mar; 28(3):303-7. PubMed ID: 16173650
[TBL] [Abstract][Full Text] [Related]
12. Ramelteon: a novel treatment for the treatment of insomnia.
Wurtman R
Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune hepatitis in association with ramelteon.
Fourman LT; Robert Meyer B
J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362
[TBL] [Abstract][Full Text] [Related]
14. Ramelteon: a review of its therapeutic potential in sleep disorders.
Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.
Miyamoto M
CNS Neurosci Ther; 2009; 15(1):32-51. PubMed ID: 19228178
[TBL] [Abstract][Full Text] [Related]
16. Ramelteon: a novel approach in the treatment of insomnia.
Reynoldson JN; Elliott E; Nelson LA
Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
[TBL] [Abstract][Full Text] [Related]
17. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
Fisher SP; Davidson K; Kulla A; Sugden D
J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
[TBL] [Abstract][Full Text] [Related]
19. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Imbesi M; Uz T; Manev H
Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
[TBL] [Abstract][Full Text] [Related]
20. A Case of Unilateral Hypnic Headache: Rapid Response to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist.
Arai M
Headache; 2015; 55(7):1010-1. PubMed ID: 26121162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
